Allarity Therapeutics (NASDAQ:ALLR) Given New $9.75 Price Target at Ascendiant Capital Markets
Allarity Therapeutics (NASDAQ:ALLR – Get Free Report) had its target price lifted by research analysts at Ascendiant Capital Markets from $9.50 to $9.75 in a research note issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Allarity Therapeutics in […]
10 Apr 12:12 · The Markets Daily